|
ZNF330 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.981400E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.430300E-04 |
| Normal-vs-Stage2 |
7.316600E-01 |
| Normal-vs-Stage3 |
5.359800E-01 |
| Normal-vs-Stage4 |
7.480300E-02 |
| Stage1-vs-Stage2 |
1.776560E-01 |
| Stage1-vs-Stage3 |
5.428400E-01 |
| Stage1-vs-Stage4 |
6.260400E-01 |
| Stage2-vs-Stage3 |
7.575000E-01 |
| Stage2-vs-Stage4 |
2.084000E-01 |
| Stage3-vs-Stage4 |
4.015200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.638300E-03 |
| Normal-vs-AfricanAmerican |
8.181800E-02 |
| Normal-vs-Asian |
6.158600E-01 |
| Caucasian-vs-AfricanAmerican |
9.920800E-01 |
| Caucasian-vs-Asian |
4.669400E-01 |
| AfricanAmerican-vs-Asian |
4.703600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.481600E-03 |
| Normal-vs-Female |
7.122000E-02 |
| Male-vs-Female |
8.197000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.528790E-01 |
| Normal-vs-Extreme_Weight |
9.199900E-03 |
| Normal-vs-Obese |
3.952200E-02 |
| Normal-vs-Extreme_Obese |
9.398200E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.696200E-01 |
| Normal_Weight-vs-Obese |
9.204200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.579400E-01 |
| Extreme_Weight-vs-Obese |
6.961000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.660200E-01 |
| Obese-vs-Extreme_Obese |
3.356400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.038800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.481400E-03 |
| Normal-vs-Age(61-80Yrs) |
4.767500E-02 |
| Normal-vs-Age(81-100Yrs) |
2.736800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.034000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.490600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.525400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.626800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.905600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.079200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.60800000000139E-05 |
| Normal-VS-Type2 PRCC |
7.831800E-01 |
| Normal-VS-KIRP CIMP |
2.131600E-02 |
| Normal-VS-Unclassified PRCC |
4.792200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.671800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.495640E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.873700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.062780E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.613200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.878400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.535600E-01 |
| Normal-vs-N1 |
2.214000E-01 |
| Normal-vs-N2 |
2.441400E-04 |
| N0-vs-N1 |
7.535000E-01 |
| N0-vs-N2 |
7.324200E-03 |
| N1-vs-N2 |
3.006000E-02 |
|
|
